Stock listing

ZA71 Stock Price, News, Filings & Events — Larimar Therapeutics, Inc.

Selected listing: ZA71 · TRADEGATE · EUR · DE

The selected listing for Larimar Therapeutics, Inc. is ZA71:TRADEGATE. The company focuses on developing innovative therapies for rare diseases, particularly targeting conditions like Friedreich's ataxia. Recent news highlights their ongoing clinical trials and regulatory filings, which are crucial for advancing their treatment options. Investors can stay updated on upcoming events and market developments that may impact the company's progress and stock performance.

ZA71:TRADEGATEEURDEUpdated July 24, 2026
Larimar Therapeutics, Inc. logo
Ticker
ZA71:TRADEGATE
Asset type
Stock
Market cap
$415.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Larimar Therapeutics, Inc. ZA71:TRADEGATE stock context

The selected listing for Larimar Therapeutics, Inc. is ZA71:TRADEGATE. The company focuses on developing innovative therapies for rare diseases, particularly targeting conditions like Friedreich's ataxia. Recent news highlights their ongoing clinical trials and regulatory filings, which are crucial for advancing their treatment options. Investors can stay updated on upcoming events and market developments that may impact the company's progress and stock performance.

Research Larimar Therapeutics, Inc.

Alternate listings